DAVID P LYNCH

Allopathic & Osteopathic Physicians|Family Medicine BLACKLICK, OH NPI 1013987049

General Payments — all program years on this page

$440.54

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $307.27 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $307.2716

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $88.224
Abbott Laboratories $83.504
Phathom Pharmaceuticals, Inc. $32.502
Novo Nordisk AS $29.722
Lilly USA, LLC $20.441
GlaxoSmithKline, LLC. $19.641
Merck Sharp & Dohme Corporation $16.821
Amgen Inc. $16.431

By program year

Program yearAmountRecords
2018 $10.971
2023 $122.306
2024 $307.2716

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096569414 Novo Nordisk Inc $14.26 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096624600 Novo Nordisk Inc $15.46 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104915481 ABBVIE INC. $22.02 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104915483 ABBVIE INC. $14.44 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104915485 ABBVIE INC. $29.75 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104915487 ABBVIE INC. $22.01 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111639102 Amgen Inc. $16.43 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116547279 GlaxoSmithKline, LLC. $19.64 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798512 Abbott Laboratories $21.53 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798514 Abbott Laboratories $21.37 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798516 Abbott Laboratories $19.92 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124798518 Abbott Laboratories $20.68 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136147717 Lilly USA, LLC $20.44 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141979187 Merck Sharp & Dohme LLC $16.82 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151091111 Phathom Pharmaceuticals, Inc. $14.97 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151091113 Phathom Pharmaceuticals, Inc. $17.53 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.